NYBC Ventures
Corporate VC arm of New York Blood Center Enterprises deploying a $50M fund into early-stage companies advancing hematology, transfusion medicine, cell therapy, and infectious disease.
Offices
Investment Focus
Founded
2021
Investment Themes
Corporate VC
Early Stage
Thesis-Driven
Bio/Health-Focused
Impact-Focused
You're viewing 1 investor
Go from one investor to the complete database.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →Similar Investors
MPM BioImpact
Seed · Series A · Series B
Boston
Arkin Bio Ventures
Seed · Series A · Series B
Herzliya
Ki Tua Fund
Seed · Series A · Series B
Auckland
Lilly Asia Ventures (LAV Fund)
Seed · Series A · Series B
Hong Kong · Shanghai +1
Modi Ventures
Pre-Seed · Seed · Series A
Houston
Novalis Biotech
Pre-Seed · Seed · Series A
Ghent
Related Investor Lists
Still just 1 investor
Get the complete database — not just this profile.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →